BlackBerry and NantHealth Launch Breakthrough NantOmics Cancer Genome Browser
December 08 2014 - 5:00AM
Business Wire
Secure Technology Enables Real-Time
Assessment and Diagnosis at Molecular Level at Point of
Care
First Product in Innovative Partnership
Transforming Healthcare placing a super-computer in the palm of a
doctor’s hand
BlackBerry Limited (NASDAQ: BBRY; TSX: BB), a global leader in
mobile communications, and NantHealth, a cloud-based information
technology provider combining science and big data to transform
healthcare, today announced the first secure clinical genome
browser that gives doctors unprecedented access to patients’
genetic data on the BlackBerry® Passport smartphone – the NantOmics
Cancer Genome Browser™.
The NantOmics Cancer Genome Browser platform on the BlackBerry
Passport enables deep, interactive reporting on genomics data for
physicians and other treatment providers in clinical settings – for
example, giving oncologists a powerful view into the individual
genetic alternations that make each patient’s disease unique and
highlighting relevant treatment options. The BlackBerry Passport’s
large high resolution screen enables clinicians to view a patient’s
chromosome at an individual base-pair level. It is the first in a
series of innovative offerings being developed jointly by
BlackBerry and NantHealth for use by healthcare professionals.
“BlackBerry’s partnership with NantHealth illustrates how the
mobile security and collaboration technology we are known for can
be reimagined to create revolutionary applications across a variety
of industries,” said John Chen, Executive Chairman and CEO,
BlackBerry. “BlackBerry technology has proven itself secure,
reliable and powerful enough to be counted on in life-and-death
situations. Its innovative form and functionality make BlackBerry
Passport an ideal addition to a doctor’s medical kit.”
“The proprietary NantOmics Cancer Genome Browser enables
clinicians for the first time to investigate a tumor genome from
the full three billion bases down to the single-base level in
real-time, thanks to the power of the NantOmics supercomputing
infrastructure,” said Patrick Soon-Shiong, M.D., founder and CEO of
NantHealth. “This integrates with NantHealth’s treatment
recommendation engine, Eviti, to personalize treatment protocols to
individual patients based on their genomic signature.”
Powered by BlackBerry’s mobile security infrastructure, the
NantOmics Cancer Genome Browser is fully encrypted to allow
deployment in a HIPAA-secured environment, enabling clinicians to
securely access patient data as soon as it’s available, wherever
they are. BlackBerry’s recently launched BES12 cross-platform EMM
solution will enable hospital IT administrators to easily deploy
the application to a clinician’s BlackBerry Passport smartphone and
ensures that the application data is fully secure end-to-end.
“BlackBerry already powers many of the diagnostic machines
clinicians rely heavily upon so it makes sense to tie those devices
directly to a BlackBerry smartphone,” said Soon-Shiong. “NantHealth
has quietly built the unique capability of placing a super-computer
into the doctor’s hand at point of care and in time of need. Now
with BlackBerry’s partnership and through the power of the cloud
and secure networks, the reality is we are now able to put dozens
of supercomputers, through mobile devices, into doctor’s hands on a
global basis. Our goal is to extend this unique capability from
doctor to patient, thereby establishing patient empowered 21st
century health.”
The NantOmics Cancer Genome Browser will be
demonstrated at the Consumer Electronics Show (CES) in January and
will be preloaded on BlackBerry Passport devices and available to
the professional community in early 2015.
About BlackBerry
A global leader in mobile communications, BlackBerry®
revolutionized the mobile industry when it was introduced in 1999.
Today, BlackBerry aims to inspire the success of our millions of
customers around the world by continuously pushing the boundaries
of mobile experiences. Founded in 1984 and based in Waterloo,
Ontario, BlackBerry operates offices in North America, Europe,
Middle East and Africa, Asia Pacific and Latin America. The Company
trades under the ticker symbols "BB" on the Toronto Stock Exchange
and "BBRY" on the NASDAQ. For more information, visit
www.BlackBerry.com.
About NantOmics
NantOmics is a leading medical diagnostic company dedicated to
providing actionable intelligence and molecularly driven decision
support for cancer patients and their providers at the point of
care. NantOmics is the first molecular diagnostics company to
pioneer an integrated approach to unearthing the genomic and
proteomic variances that initiate and drive cancer, by analyzing
both normal and tumor cells from the same patient and following
identified variances through from DNA to RNA to protein to drug.
NantOmics has a highly scalable cloud-based infrastructure capable
of storing and processing thousands of genomes a day, computing
genomic variances in near real-time, and correlating proteomic
pathway analysis with quantitative multi-plexed protein expression
analysis from the same micro-dissected tumor sample used for
genomic analysis. For more information
visit www.nantomics.com.
About NantHealth
NantHealth, a member of the NantWorks ecosystem of companies, is
a transformational healthcare cloud-based IT company converging
science and technology through a single integrated clinical
platform, to provide actionable health information at the point of
care, in the time of need, anywhere, anytime. NantHealth works to
transform clinical delivery with actionable clinical intelligence
at the moment of decision, enabling clinical discovery through
real-time machine learning systems. The company’s technology
empowers physicians, patients, payers and researchers to transcend
the traditional barriers of today’s healthcare system. By
converging molecular science, near real-time patient signal
monitoring, computer science and big data technology, the
NantHealth Clinical Operating System (cOS) platform empowers
physicians, patients, and payers to coordinate best care, monitor
outcomes and control cost in real time. This is the first system of
its kind in healthcare, enabling 21st century coordinated care at a
lower cost, enabling value-based population health management at a
single patient level and at the population at large. For more
information please visit www.nanthealth.com.
NantHealthJen Hodson, 562-397-3639jhodson@nantworks.com
BlackBerry Ltd. (NASDAQ:BBRY)
Historical Stock Chart
From Apr 2024 to May 2024
BlackBerry Ltd. (NASDAQ:BBRY)
Historical Stock Chart
From May 2023 to May 2024